Authors:
Cherpelis, S
Jin, X
Gettie, A
Ho, DD
Barnett, SW
Shrivastava, I
Stamatatos, L
Citation: S. Cherpelis et al., DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques, IMMUNOL LET, 79(1-2), 2001, pp. 47-55
Authors:
Cherpelis, S
Shrivastava, I
Gettie, A
Jin, X
Ho, DD
Barnett, SW
Stamatatos, L
Citation: S. Cherpelis et al., DNA vaccination with the human immunodeficiency virus type 1 SF162 Delta V2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques, J VIROLOGY, 75(3), 2001, pp. 1547-1550
Authors:
Barnet, SW
Lu, S
Srivastava, I
Cherpelis, S
Gettie, A
Blanchard, J
Wang, S
Mboudjeka, I
Leung, L
Lian, Y
Fong, A
Buckner, C
Ly, A
Hilt, S
Ulmer, J
Wild, CT
Mascola, JR
Stamatatos, L
Citation: Sw. Barnet et al., The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region, J VIROLOGY, 75(12), 2001, pp. 5526-5540
Citation: L. Stamatatos et al., Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptibleprimary HIV type 1 isolates, AIDS RES H, 16(10), 2000, pp. 981-994
Citation: A. Ly et L. Stamatatos, V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCRS receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies, J VIROLOGY, 74(15), 2000, pp. 6769-6776
Authors:
Ignatius, R
Mahnke, K
Rivera, M
Hong, K
Isdell, F
Steinman, RM
Pope, M
Stamatatos, L
Citation: R. Ignatius et al., Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8(+) T-cell responses in vivo, BLOOD, 96(10), 2000, pp. 3505-3513